Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Comera Life Sciences Holdings, Inc.
| Metric | Comera Life Sciences Holdings, Inc. CMRAHealthcare |
|---|---|
| Quality Score | 52 / 100 |
| Revenue (latest) | $633,102 |
| Net income (latest) | −$18M |
| Operating margin | −1890.7% |
| Net margin | −2843.8% |
| Return on equity | 288.2% |
| Return on assets | −483.1% |
| Return on capital (ROCE) | — |
| Debt / equity | — |
| Revenue growth (YoY) | 97.9% |
| Altman Z″ (distress) | -56.83 |
| Accruals / assets | −220.9% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.